Related Experiment Video
Updated: Jun 3, 2025

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
Reversible Perfusion Changes during Acute Attacks in Glucose Transporter Type 1 Deficiency Syndrome: A Pediatric Case
Francesco Pacchiano1, Chiara Doneda2, Filippo Arrigoni2
1From the Department of Precision Medicine (F.P.), University of Campania "L. Vanvitelli," Caserta, Italy fpacchiano1@gmail.com.
Insights
Glucose transporter type 1 deficiency syndrome (GLUT1-DS) causes infantile seizures and movement disorders. New imaging reveals reversible brain hypoperfusion during stroke-like episodes, aiding understanding of GLUT1-DS acute symptoms.
Area of Science:
- Neurology
- Pediatrics
- Medical Imaging
Background:
- Glucose transporter type 1 deficiency syndrome (GLUT1-DS) is an infantile-onset disorder linked to SLC2A1 gene mutations.
- Clinical features include seizures, developmental delay, movement disorders, and stroke-like episodes.
- The underlying pathomechanism of acute transient symptoms in GLUT1-DS remains unclear, with standard MRI often showing nonspecific findings.
Purpose of the Study:
- To investigate the acute pathophysiological changes during stroke-like episodes in pediatric patients with GLUT1-DS.
- To evaluate the utility of arterial spin-labeling (ASL) perfusion imaging and magnetic resonance angiography (MRA) in characterizing these events.
Main Methods:
- ASL perfusion imaging and MRA were performed during acute stroke-like episodes in 4 pediatric patients with GLUT1-DS.
- Imaging findings were analyzed to identify perfusion abnormalities and vascular changes.
Main Results:
- Reversible hypoperfusion was observed in the affected cerebral hemisphere.
- Reversible attenuation of distal Middle Cerebral Artery (MCA) branches was noted on MRA.
- A correlation between unilateral cerebral hypoperfusion and transient crossed cerebellar diaschisis was identified on perfusion maps.
Conclusions:
- ASL and MRA can detect reversible perfusion deficits and vascular changes during acute stroke-like episodes in GLUT1-DS.
- These findings suggest that transient hypoperfusion plays a role in the acute neurological manifestations of GLUT1-DS.
- Advanced imaging techniques offer insights into the poorly understood pathomechanism of acute symptoms in this syndrome.
Abstract:
Glucose transporter type 1 deficiency syndrome (GLUT1-DS) is an uncommon condition represented by an infantile-onset disorder, frequently arising from heterozygous mutations in the SLC2A1 gene. Individuals with GLUT1-DS may present with early-onset seizures (typically manifesting before 4 years of age), developmental delay, and complex movement disorders. In fewer cases, stroke-like events or hemiplegic migraine-like symptoms are also reported, defined by unilateral paresis affecting 1 side of the body and/or one-half of the face, occasionally accompanied by speech impairment. Currently, the pathomechanism underlying these acute transient clinical manifestations is poorly understood. MR imaging studies performed in the absence of acute manifestations frequently reveal nonspecific imaging signs associated with this syndrome. We present findings obtained using the arterial spin-labeling technique for perfusion imaging and MRA during the acute onset of stroke-like episodes in a series of 4 pediatric patients with GLUT1-DS. We observed reversible hypoperfusion in the left hemisphere and associated reversible attenuation of distal MCA branches on MRA. A notable association between unilateral cerebral hypoperfusion and transient crossed cerebellar diaschisis was evident on perfusion maps as well.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

